- ASLAN Pharmaceuticals (NASDAQ:ASLN): Q1 GAAP EPADS of -$0.13.
- Cash and cash equivalents of $100.82M.
- Press Release
ASLAN Pharmaceuticals reports Q1 results
Recommended For You
More Trending News
About ASLN Stock
Related Stocks
| Symbol | Last Price | % Chg |
|---|---|---|
| ASLN | - | - |
| ASLAN Pharmaceuticals Limited | ||